Superior Planning, LLC’s CorMedix CRMD Stock Holding History

Superior Planning, LLC’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$585	Buy	+76	New	+$609	﹤0.01%	1857

Other funds holding CRMD

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Superior Planning, LLC's CRMD Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in CorMedix (CRMD) in Q3 2026: 76 shares worth $585. The stake represents ﹤0.01% of the portfolio and ranks #1857 among its holdings.

106 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

Superior Planning, LLC held 76 shares of CorMedix worth $585 as of Q3 2026.
CorMedix was a new Superior Planning, LLC position in Q3 2026.
CorMedix made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1857 holding.
106 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.